Q9HB96 (FANCE_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 105.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Fanconi anemia group E protein Short name=Protein FACE | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 536 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | As part of the Fanconi anemia (FA) complex functions in DNA cross-links repair. Required for the nuclear accumulation of FANCC and provides a critical bridge between the FA complex and FANCD2. Ref.7 Ref.12 |
| Subunit structure | Belongs to the multisubunit FA complex composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM. The complex is not found in FA patients. Interacts with FANCC and FANCD2. Ref.8 Ref.9 Ref.10 Ref.11 Ref.16 |
| Subcellular location | |
| Post-translational modification | Phosphorylated. Phosphorylation by CHEK1 at Thr-346 and Ser-374 regulates its function in DNA cross-links repair. Ref.12 Ubiquitinated. Phosphorylation by CHEK1 induces polyubiquitination and degradation. Ref.12 |
| Involvement in disease | Fanconi anemia complementation group E (FANCE) [MIM:600901]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. |
Ontologies
| Keywords | |
|---|---|
| Biological process | DNA damage DNA repair |
| Cellular component | Nucleus |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation Fanconi anemia |
| PTM | Phosphoprotein Ubl conjugation |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | DNA repair Traceable author statement. Source: Reactome |
| Cellular_component | Fanconi anaemia nuclear complex Inferred from direct assay PubMed 20347428Ref.16. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| FANCC | Q00597 | 3 | EBI-396803,EBI-81625 | |
| FANCD2 | Q9BXW9 | 4 | EBI-396803,EBI-359343 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 536 | 536 | Fanconi anemia group E protein | PRO_0000087187 | |||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||
| Region | 150 – 371 | 222 | Interaction with FANCC | ||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 249 | 1 | Phosphoserine Ref.13 Ref.14 Ref.15 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 346 | 1 | Phosphothreonine; by CHEK1 | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 374 | 1 | Phosphoserine; by CHEK1 | ||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 89 | 1 | R → L. Ref.2 Corresponds to variant rs45600543 [ dbSNP | Ensembl ]. | VAR_023372 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 184 | 1 | P → Q in FA; uncertain pathological significance. Ref.17 | VAR_038022 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 204 | 1 | S → L. Ref.2 Corresponds to variant rs7761870 [ dbSNP | Ensembl ]. | VAR_023373 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 340 | 1 | G → R. Ref.2 Corresponds to variant rs45524646 [ dbSNP | Ensembl ]. | VAR_023374 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 343 | 1 | R → Q. Ref.2 Corresponds to variant rs45467798 [ dbSNP | Ensembl ]. | VAR_023375 | |||||||||||||||||||||||||||||||||||||||
| Natural variant | 502 | 1 | A → T. Ref.2 Corresponds to variant rs9462088 [ dbSNP | Ensembl ]. | VAR_023376 | |||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 346 | 1 | T → A: Non-phosphorylatable by CHEK1, not polyubiquitinated and unable to complement the mitomycin C hypersensitivity of cells lacking FANCE; when associated with A-374. Ref.12 | ||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 374 | 1 | S → A: Non-phosphorylatable by CHEK1, not polyubiquitinated and unable to complement the mitomycin C hypersensitivity of cells lacking FANCE; when associated with A-346. Ref.12 | ||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||
| Helix | 282 – 299 | 18 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 311 – 314 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 315 – 318 | 4 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 321 – 331 | 11 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 333 – 335 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 338 – 350 | 13 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 357 – 374 | 18 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 381 – 393 | 13 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 395 – 408 | 14 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 414 – 425 | 12 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 431 – 443 | 13 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 448 – 458 | 11 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 466 – 477 | 12 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 487 – 499 | 13 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 501 – 503 | 3 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 506 – 516 | 11 | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 518 – 523 | 6 | |||||||||||||||||||||||||||||||||||||||||
| Helix | 524 – 534 | 11 | |||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of a cDNA representing the Fanconi anemia complementation group E gene." de Winter J.P., Leveille F., van Berkel C.G.M., Rooimans M.A., van der Weel L., Steltenpool J., Demuth I., Morgan N.V., Alon N., Bosnoyan-Collins L., Lightfoot J., Leegwater P.A., Waisfisz Q., Komatsu K., Arwert F., Pronk J.C., Mathew C.G., Digweed M., Buchwald M., Joenje H. Am. J. Hum. Genet. 67:1306-1308(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], DISEASE. |
| [2] | NIEHS SNPs program Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LEU-89; LEU-204; ARG-340; GLN-343 AND THR-502. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Testis. |
| [4] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Eye. |
| [7] | "FANCE: the link between Fanconi anaemia complex assembly and activity." Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M.E., de Winter J.P., Joenje H., Gergely F., Patel K.J. EMBO J. 21:3414-3423(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [8] | "Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems." Gordon S.M., Buchwald M. Blood 102:136-141(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FANCC AND FANCD2. |
| [9] | "A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome." Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H., Hoatlin M.E., Wang W. Mol. Cell. Biol. 23:3417-3426(2003) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH FANCA; FANCC; FANCF; FANCG AND FANCL. |
| [10] | "X-linked inheritance of Fanconi anemia complementation group B." Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C., Rooimans M.A., Bier P., Hoatlin M., Pals G., de Winter J.P., Wang W., Joenje H. Nat. Genet. 36:1219-1224(2004) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH FANCA; FANCB; FANCC; FANCF; FANCG AND FANCL. |
| [11] | "A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M." Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C.G., Hoatlin M., Joenje H., de Winter J.P., Wang W. Nat. Genet. 37:958-963(2005) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH FANCA; FANCB; FANCC; FANCF; FANCG; FANCL AND FANCM. |
| [12] | "Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway." Wang X., Kennedy R.D., Ray K., Stuckert P., Ellenberger T., D'Andrea A.D. Mol. Cell. Biol. 27:3098-3108(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN DNA REPAIR, SUBCELLULAR LOCATION, PHOSPHORYLATION BY CHEK1 AT THR-346 AND SER-374, MUTAGENESIS OF THR-346 AND SER-374, UBIQUITINATION. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [15] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, MASS SPECTROMETRY. |
| [16] | "Regulation of Rev1 by the Fanconi anemia core complex." Kim H., Yang K., Dejsuphong D., D'Andrea A.D. Nat. Struct. Mol. Biol. 19:164-170(2012) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE FA COMPLEX. |
| [17] | "Genetic subtyping of Fanconi anemia by comprehensive mutation screening." Ameziane N., Errami A., Leveille F., Fontaine C., de Vries Y., van Spaendonk R.M., de Winter J.P., Pals G., Joenje H. Hum. Mutat. 29:159-166(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT FA GLN-184. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF265210 mRNA. Translation: AAG16743.1. DQ020173 Genomic DNA. Translation: AAY26395.1. AK292522 mRNA. Translation: BAF85211.1. AL022721 Genomic DNA. Translation: CAD92504.1. CH471081 Genomic DNA. Translation: EAX03830.1. BC046359 mRNA. Translation: AAH46359.1. | ||||||||||||
| IPI | IPI00030252. | ||||||||||||
| RefSeq | NP_068741.1. NM_021922.2. | ||||||||||||
| UniGene | Hs.302003. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q9HB96. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-32845N. | ||||||||||||
| IntAct | Q9HB96. 7 interactions. | ||||||||||||
| MINT | MINT-157013. | ||||||||||||
| STRING | 9606.ENSP00000229769. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9HB96. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 45476978. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q9HB96. | ||||||||||||
| PRIDE | Q9HB96. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000229769; ENSP00000229769; ENSG00000112039. | ||||||||||||
| GeneID | 2178. | ||||||||||||
| KEGG | hsa:2178. | ||||||||||||
| UCSC | uc003oko.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 2178. | ||||||||||||
| GeneCards | GC06P035563. | ||||||||||||
| HGNC | HGNC:3586. FANCE. | ||||||||||||
| HPA | CAB014893. | ||||||||||||
| MIM | 600901. phenotype. 613976. gene. | ||||||||||||
| neXtProt | NX_Q9HB96. | ||||||||||||
| Orphanet | 84. Fanconi anemia. | ||||||||||||
| PharmGKB | PA28000. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG42377. | ||||||||||||
| HOGENOM | HOG000013179. | ||||||||||||
| InParanoid | Q9HB96. | ||||||||||||
| KO | K10892. | ||||||||||||
| OMA | PQLCQRN. | ||||||||||||
| OrthoDB | EOG4FR0RS. | ||||||||||||
| PhylomeDB | Q9HB96. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | bard1pathway. BARD1 signaling events. | ||||||||||||
| Reactome | REACT_216. DNA Repair. | ||||||||||||
Gene expression databases | |||||||||||||
| Bgee | Q9HB96. | ||||||||||||
| CleanEx | HS_FANCE. | ||||||||||||
| Genevestigator | Q9HB96. | ||||||||||||
| GermOnline | ENSG00000112039. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR021025. Fanconi_anaemia_gr_E_prot_C. [Graphical view] | ||||||||||||
| Pfam | PF11510. FA_FANCE. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q9HB96. | ||||||||||||
| GenomeRNAi | 2178. | ||||||||||||
| NextBio | 8797. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | FANCE_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9HB96 Secondary accession number(s): A8K907, Q4ZGH2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |

Clusters with
